Ziv Ester, Rotem Carmela, Miodovnik Mor, Ravid Amiram, Koren Ruth
The Basil and Gerald Felsenstein Medical Research Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
J Cell Biochem. 2008 May 15;104(2):606-19. doi: 10.1002/jcb.21650.
Inflammation, elicited in the skin following tissue damage or pathogen invasion, may become chronic with deleterious consequences. Tumor necrosis factor (TNF) is a key mediator of cutaneous inflammation and the keratinocyte an important protagonist of skin immunity. Calcitriol, the hormonally active vitamin D metabolite, and its analogs attenuate epidermal inflammation and inhibit the hyperproliferation of keratinocytes associated with the inflammatory disorder, psoriasis. Since activation of extracellular signal-regulated kinase (ERK) promotes keratinocyte proliferation and mediates epidermal inflammation, we studied the effect of calcitriol on ERK activation in HaCaT keratinocytes exposed to the ubiquitous inflammatory cytokine TNF. By using the EGF receptor (EGFR) tyrosine kinase inhibitor, AG1487 and the Src family inhibitor, PP-1, we established that TNF activated ERK in an EGFR and Src dependent and an EGFR and Src independent modes. EGFR dependent activation resulted in the upregulation of the transcription factor, c-Fos, while the EGFR independent activation mode was of a shorter duration, did not affect c-Fos expression but induced IL-8 mRNA expression. Pretreatment with calcitriol, enhanced TNF-induced EGFR-Src dependent ERK activation and tyrosine phosphorylation of the EGFR, but abolished the EGFR-Src independent ERK activation. These effects were mirrored by enhancement of c-Fos and inhibition of IL-8 induction by TNF. Treatment with calcitriol increased the rate of the de-phosphorylation of activated ERK, accounting for the inhibition of EGFR-Src independent ERK activation by TNF. It is possible that effects on the ERK cascade contribute to the effects of calcitriol and its synthetic analogs on cutaneous inflammation and keratinocyte proliferation.
组织损伤或病原体入侵后皮肤引发的炎症可能会发展为慢性炎症,并产生有害后果。肿瘤坏死因子(TNF)是皮肤炎症的关键介质,而角质形成细胞是皮肤免疫的重要参与者。骨化三醇,即具有激素活性的维生素D代谢产物及其类似物,可减轻表皮炎症,并抑制与炎症性疾病银屑病相关的角质形成细胞过度增殖。由于细胞外信号调节激酶(ERK)的激活促进角质形成细胞增殖并介导表皮炎症,我们研究了骨化三醇对暴露于普遍存在的炎症细胞因子TNF的HaCaT角质形成细胞中ERK激活的影响。通过使用表皮生长因子受体(EGFR)酪氨酸激酶抑制剂AG1487和Src家族抑制剂PP-1,我们确定TNF以EGFR和Src依赖性以及EGFR和Src非依赖性模式激活ERK。EGFR依赖性激活导致转录因子c-Fos上调,而EGFR非依赖性激活模式持续时间较短,不影响c-Fos表达,但诱导IL-8 mRNA表达。骨化三醇预处理增强了TNF诱导的EGFR-Src依赖性ERK激活和EGFR的酪氨酸磷酸化,但消除了EGFR-Src非依赖性ERK激活。这些作用反映在TNF增强c-Fos并抑制IL-8诱导上。骨化三醇处理增加了活化ERK的去磷酸化速率,这解释了TNF对EGFR-Src非依赖性ERK激活的抑制作用。对ERK级联反应的影响可能有助于骨化三醇及其合成类似物对皮肤炎症和角质形成细胞增殖的作用。